Catherine H Poznak

Catherine H Van Poznak

UNVERIFIED PROFILE

Are you Catherine H Van Poznak?   Register this Author

Register author
Catherine H Poznak

Catherine H Van Poznak

Publications by authors named "Catherine H Van Poznak"

35Publications

940Reads

46Profile Views

1PubMed Central Citations

Phase II randomized controlled trial of hypnosis versus progressive muscle relaxation for body image after breast or gynecologic cancer.

Breast Cancer Res Treat 2019 Aug 9. Epub 2019 Aug 9.

Department of Internal Medicine - Hematology/Oncology, University of Michigan, Ann Arbor, MI, 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05395-6DOI Listing
August 2019

Oral health-related concerns, behavior, and communication with health care providers of patients with breast cancer: impact of different treatments.

Spec Care Dentist 2018 Jan 16;38(1):36-45. Epub 2018 Jan 16.

Professor, Department of Periodontics and Oral Medicine, School of Dentistry & Department of Psychology, College of Literature, Science & Arts, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/scd.12266DOI Listing
January 2018

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2017 Jun 6;35(18):2062-2081. Epub 2017 Mar 6.

Sukhbinder Dhesy-Thind, Juravinski Cancer Centre; Sukhbinder Dhesy-Thind and Glenn G. Fletcher, McMaster University, Hamilton, Ontario; Phillip S. Blanchette, Sunnybrook Odette Cancer Centre; Sonal Gandhi, Sunnybrook Health Sciences, Toronto, Ontario; Mark J. Clemons, The Ottawa Hospital Cancer Centre, Ottawa, Ontario; Rasna Gupta, Windsor Regional Cancer Program, Windsor, Ontario; Mihaela Mates, Kingston General Hospital, Kingston, Ontario; Ted Vandenberg, London Health Sciences Centre, London, Ontario, Canada; Melissa S. Dillmon, Harbin Clinic, Rome, GA; Elizabeth S. Frank, Lexington; Beverly Moy, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA; and Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7257DOI Listing
June 2017

Self-reported oral health and quality of life of postmenopausal breast cancer survivors on aromatase inhibitors and women without cancer diagnoses: a longitudinal analysis.

Support Care Cancer 2016 11 25;24(11):4815-24. Epub 2016 Jul 25.

Department of Periodontics and Oral Medicine, School of Dentistry & Department of Psychology, College of Literature, Science & Arts, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-016-3336-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614704PMC
November 2016

Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.

J Clin Oncol 2016 07 21;34(20):2359-65. Epub 2016 Mar 21.

Tari A. King, Jaclyn P. Lyman, Mithat Gonen, Amy Voci, Marina De Brot, Camilla Boafo, Larry Norton, Monica Morrow, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Amy Pratt Sing, Genomic Health, Redwood City; Michael D. Alvarado, University of California San Francisco Comprehensive Cancer Center, San Francisco, CA; E. Shelley Hwang, Duke University School of Medicine, Durham, NC; Minetta C. Liu, Georgetown University Medical Center, Washington, DC; Judy C. Boughey, Mayo Clinic, Rochester, MN; Kandace P. McGuire, University of Pittsburgh, Pittsburgh, PA; Catherine H. Van Poznak, University of Michigan Medical School, Ann Arbor, MI; Lisa K. Jacobs, Johns Hopkins University School of Medicine, Baltimore, MD; Ingrid M. Meszoely, Vanderbilt University Medical Center, Nashville, TN; Helen Krontiras, University of Alabama at Birmingham School of Medicine, Birmingham, AL; and Gildy V. Babiera, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1960DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981976PMC
July 2016

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.

J Clin Oncol 2016 Mar 1;34(9):945-52. Epub 2016 Feb 1.

Rachel A. Freedman, Rebecca S. Gelman, Christina Herold, Nicole Ryabin, Sarah Farooq, Elizabeth Lawler, Ian E. Krop, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital; Alarice Lowe and Nathalie Y.R. Agar, Brigham and Women's Hospital, Boston, MA; Jeffrey S. Wefel, Kenneth R. Hess, and Nuhad Ibrahim, The University of Texas MD Anderson Cancer Center; Polly A. Niravath and Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; Michelle E. Melisko, University of California, San Francisco, San Francisco, CA; Roisin M. Connolly and Antonio C. Wolff, Johns Hopkins University, Baltimore, MD; Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI; Shannon L. Puhalla, University of Pittsburgh Cancer Institute and Magee-Women's Hospital, Pittsburgh, PA; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; and Minetta C. Liu, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/01/28/JCO.2015.63
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.63.0343
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.63.0343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070554PMC
March 2016

Bone health in adults treated with endocrine therapy for early breast or prostate cancer.

Am Soc Clin Oncol Educ Book 2015 :e567-74

From the Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI 5848.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.e567DOI Listing
February 2016

Clinical predictors of long-term survival in HER2-positive metastatic breast cancer.

Breast Cancer Res Treat 2016 Feb 13;155(3):589-95. Epub 2016 Feb 13.

Internal Medicine/Hematology/Oncology, University of Michigan Medical School, 1500 East Medical Center Dr, Med Inn Bldg C450, Ann Arbor, MI, 48109-5843, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3705-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895232PMC
February 2016

Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analyses.

Mol Oncol 2015 Nov 29;9(9):1868-76. Epub 2015 Jul 29.

Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Health System, Ann Arbor, MI, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624024PMC
November 2015

Potential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancer.

Breast Cancer Res Treat 2013 Jan 18;137(1):23-32. Epub 2012 Sep 18.

Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, 1011 North University Ave., Ann Arbor, MI 48109-1078, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-012-2217-z
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2217-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529782PMC
January 2013

Sixty is the new forty--or is it the other way around?

Oncology (Williston Park) 2012 Oct;26(10):963, 969

Monter Cancer Center of the North Shore LIJ Cancer Institute, Hofstra North Shore LIJ School of Medicine, Lake Success, New York, USA.

View Article

Download full-text PDF

Source
October 2012

American society of clinical oncology clinical practice guideline update: recommendations on the role of bone-modifying agents in metastatic breast cancer.

J Oncol Pract 2011 Mar;7(2):117-21

University of Michigan, Ann Arbor, MI; Lurie Comp Cancer Center of Northwestern University, Chicago, IL; American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2011.000212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051857PMC
March 2011

NCCN Task Force Report: Bone Health in Cancer Care.

J Natl Compr Canc Netw 2009 Jun;7 Suppl 3:S1-32; quiz S33-5

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047404PMC
http://dx.doi.org/10.6004/jnccn.2009.0076DOI Listing
June 2009

Baseline bone mineral density of the total lumbar spine may predict for chemotherapy-induced ovarian failure.

Breast Cancer Res Treat 2005 Mar;90(1):41-6

Ohio State University Medical Center, Starling-Loving Hall, Rm B405, 320 West 10th Street, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-004-2625-9DOI Listing
March 2005

The use of bisphosphonates in patients with breast cancer.

Cancer Control 2002 Nov-Dec;9(6):480-9

Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327480200900605DOI Listing
March 2003